Stepan Company 2006 Annual Report (10-K) Summary
Business Context and Reporting Period
This filing covers the fiscal year ended December 31, 2006. Stepan Company produces specialty and intermediate chemicals sold to manufacturers for use in detergents, personal care products, plastics, building materials, and food/pharmaceutical applications. The Company operates through three reportable segments: Surfactants (75% of sales), Polymers (23% of sales), and Specialty Products (2% of sales). Operations are global, with approximately 32% of net sales generated outside the U.S.
Key Financial Metrics
| Metric | 2006 | 2005 |
|---|---|---|
| Net Sales | $1,172.6 million | $1,078.4 million |
| Operating Income | $15.9 million | $25.5 million |
| Net Income | $6.7 million | $13.2 million |
| Diluted EPS | $0.63 | $1.35 |
| Operating Margin | 1.4% | 2.4% |
| Cash Flow from Operations | $38.8 million | $42.0 million |
| Total Debt | $131.2 million | $125.7 million |
| Working Capital | $88.0 million | $96.3 million |
| Capital Expenditures | $46.0 million | $41.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% ($94.2 million) driven by higher selling prices (pass-through of raw material costs) and a 1% increase in sales volume. Foreign currency translation contributed $6.1 million.
- Profit Decline: Net income fell 49% and operating income dropped 38%. This was primarily due to a $5.2 million increase in legal and environmental expenses, a $2.8 million severance charge for European restructuring, and a $1.6 million increase in deferred compensation expenses.
- Segment Performance:
- Surfactants: Sales up 7%; Operating income up 6% despite higher expenses.
- Polymers: Sales up 16%; Operating income down 2% due to higher raw material costs and volume drops in polyurethane systems.
- Specialty Products: Sales up 7%; Operating income down 39% due to raw material cost pressures.
- Unusual Items: 2005 results were boosted by $2.5 million in insurance proceeds (UK fire) and $2.1 million in biodiesel incentives, which were not present in 2006. Conversely, 2006 included a $3.0 million settlement charge for personal injury claims at the Wilmington, MA site.
Guidance, Outlook, and Risks
- Outlook: Management expects 2007 biodiesel earnings to be lower due to lower crude oil and higher soybean oil pricing. Capital spending is projected to be flat in 2007. The Company is focused on commercializing new polyols and expanding fabric softener franchises.
- Restructuring: A restructuring of the European surfactants organization is underway, with $2.8 million in severance costs recognized in 2006. Future annual pre-tax savings are estimated at $1.5 million.
- Risks:
- Raw Material Volatility: Prices for petroleum and plant-based materials and natural gas are cyclical and volatile; the Company may not always be able to pass these costs to customers immediately.
- Environmental/Legal: The Company faces potential liabilities at 22 waste disposal sites. Accrued liabilities for environmental and legal matters were $22.1 million, with a possible loss range of $13.8 million to $42.9 million.
- Foreign Operations: Exposure to currency fluctuations, political instability, and trade restrictions in international markets.
Investor Verification Checklist
- Legal Settlements: Verify the final court approval and impact of the $3.0 million Wilmington, MA personal injury settlement.
- Environmental Reserves: Monitor the range of potential losses ($13.8M - $42.9M) and the adequacy of the $22.1M accrued liability, particularly regarding the Maywood, NJ site.
- Raw Material Pass-Through: Assess the Company's ability to maintain margins given the lag in passing raw material cost increases to customers.
- Debt Covenants: Note that the French subsidiary was out of compliance with loan covenants due to severance costs and pension accounting changes, though a waiver was obtained.
- Pension Plan Changes: Review the impact of freezing defined benefit plans and transitioning to defined contribution plans on future compensation expenses.